Biolidics

Upon completion of the proposed subscription, the new shares will represent 11.2 per cent of the enlarged issued share capital.

Biolidics’ private placement at S$0.0121 apiece to raise one-eighth of market cap

MEDTECH company Biolidics entered a subscription agreement with Chinese citizen Zhou Chao to issue and allot 83 million new shares at S$0.0121 per share on Friday (Dec 22).

2023-12-22T01:03:56.000Z

Biolidics, which produces and distributes Covid-19 test kits, has proposed issuing 98.5 million new ordinary shares at S$0.0119 apiece to raise S$1.2 million.

Companies & Markets

Clearbridge mulls Biolidics’ request for more time to repay S$2.1 million debt

CLEARBRIDGE Health is considering Biolidics’ proposal to repay its debt, which amounts to some S$2.1 million, by the extended deadline of Dec 23, 2023.

2023-11-22T09:13:12.000Z

The additional time will allow for a smooth handover of duties, says Biolidics, which previously developed Covid-19 PCR tests (pictured).

Companies & Markets

Biolidics chairman to step down at later date amid search for replacement

GAVIN Mark McIntyre, the independent chairman of Catalist-listed Biolidics, will leave his post on Nov 30 – instead of Friday (Sep 29), as previously announced when he resigned.

2023-09-29T10:49:46.000Z

UOB shall remain as Biolidics' sponsor until Dec 31, or such other date mutually agreed with the company, the new sponsor, and/or Singapore Exchange.

Companies & Markets

Biolidics’ sponsor UOB ends continuing sponsorship agreement

CATALIST-LISTED Biolidics said on Thursday (Sep 28) that its sponsor United Overseas Bank (UOB) has terminated its continuing sponsorship agreement with the company for “commercial reasons”.

2023-09-28T10:14:50.000Z

Biolidics, a diagnostic solutions provider, also produces and distributes Covid-19 test kits.

Capital Markets & Currencies

Hot stock: Biolidics nears four-month high; up 118.4% in early trade

SHARES of Catalist-listed Biolidics hit a four-month high on Wednesday (Oct 19) and was one of the most hotly traded counters by volume on the Singapore bourse.

2022-10-19T07:19:39.000Z

Companies & Markets

Corporate digest

CATALIST-LISTED medtech firm Biolidics announced on Wednesday (Dec 29) that its wholly-owned subsidiary, Biomedics Laboratory, has been granted approval by the Ministry of Health (MOH) to provide medi...

2021-12-29T13:50:00.000Z

Companies & Markets

Biolidics receives MOH nod to conduct Covid-19 PCR tests

2021-12-29T05:37:18.000Z

Companies & Markets

Biolidics to start producing new Covid-19 test using A*Star tech by year-end

CATALIST-LISTED medtech firm Biolidics expects to start commercial production of a new Covid-19 rapid test kit by year-end, the board announced on Wednesday (Dec 8).

2021-12-08T05:38:41.000Z

Companies & Markets

Corporate digest

UNITED Overseas Bank (UOB) has injected two trillion dong (S$118.9 million) worth of fresh capital into its Vietnam unit, raising its charter capital to five trillion dong from three trillion dong, th...

2021-09-21T13:50:00.000Z

Companies & Markets

Biolidics develops test detecting a person's protective immunity against Covid-19

BIOLIDICS on Monday said it has developed a new ClearEpi NAB Test product which detects an individual's protective immunity against Covid-19.

2021-09-20T16:58:30.000Z

Latest T-bills Treasury Bills Results & Interest News Latest SSB Singapore Savings Bonds News Latest COE Certificate of Entitlement News

Latest Johor-Singapore SEZ News Latest BTO Build To Order & Sales of Balance News Latest STI Straits Times Index News Latest SGX Dividends, Share Price News Latest Bonds Market News Latest Singapore Stocks To Buy News Latest Singapore Economy News